Ann Arbor-based Strata Oncology recently landed $12 million in venture capital to push forward with the development of its state-of-the-art tumor sequencing operation.
News from Concentrate
Source: SPARK
Ann Arbor-based Strata Oncology recently landed $12 million in venture capital to push forward with the development of its state-of-the-art tumor sequencing operation.
News from Concentrate
Source: SPARK
Please keep in mind that comments are moderated and rel="nofollow"
is in use. So, please do not use a spammy keyword or a domain as your name, or it will be deleted. Let us have a personal and meaningful conversation instead.